GO:0034641 | cellular nitrogen compound metabolic process | 21.58% (41/190) | 2.8 | 0.0 | 0.0 |
GO:1901566 | organonitrogen compound biosynthetic process | 13.16% (25/190) | 3.5 | 0.0 | 0.0 |
GO:0043232 | intracellular non-membrane-bounded organelle | 11.05% (21/190) | 3.7 | 0.0 | 0.0 |
GO:0043228 | non-membrane-bounded organelle | 11.05% (21/190) | 3.7 | 0.0 | 0.0 |
GO:0044249 | cellular biosynthetic process | 14.74% (28/190) | 3.01 | 0.0 | 0.0 |
GO:0043043 | peptide biosynthetic process | 10.53% (20/190) | 3.75 | 0.0 | 0.0 |
GO:0006518 | peptide metabolic process | 10.53% (20/190) | 3.69 | 0.0 | 0.0 |
GO:0044237 | cellular metabolic process | 25.26% (48/190) | 1.98 | 0.0 | 0.0 |
GO:1901363 | heterocyclic compound binding | 35.26% (67/190) | 1.54 | 0.0 | 0.0 |
GO:0097159 | organic cyclic compound binding | 35.26% (67/190) | 1.54 | 0.0 | 0.0 |
GO:0043604 | amide biosynthetic process | 10.53% (20/190) | 3.71 | 0.0 | 0.0 |
GO:1901576 | organic substance biosynthetic process | 14.74% (28/190) | 2.87 | 0.0 | 0.0 |
GO:0043603 | amide metabolic process | 10.53% (20/190) | 3.62 | 0.0 | 0.0 |
GO:0005840 | ribosome | 10.0% (19/190) | 3.74 | 0.0 | 0.0 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 12.63% (24/190) | 3.17 | 0.0 | 0.0 |
GO:0009058 | biosynthetic process | 15.26% (29/190) | 2.76 | 0.0 | 0.0 |
GO:0006412 | translation | 10.0% (19/190) | 3.71 | 0.0 | 0.0 |
GO:0003735 | structural constituent of ribosome | 10.0% (19/190) | 3.69 | 0.0 | 0.0 |
GO:0003723 | RNA binding | 11.58% (22/190) | 3.26 | 0.0 | 0.0 |
GO:0009059 | macromolecule biosynthetic process | 11.58% (22/190) | 3.25 | 0.0 | 0.0 |
GO:0005198 | structural molecule activity | 10.0% (19/190) | 3.6 | 0.0 | 0.0 |
GO:0006807 | nitrogen compound metabolic process | 25.79% (49/190) | 1.78 | 0.0 | 0.0 |
GO:0003674 | molecular_function | 55.79% (106/190) | 0.92 | 0.0 | 0.0 |
GO:0043168 | anion binding | 19.47% (37/190) | 2.11 | 0.0 | 0.0 |
GO:0035639 | purine ribonucleoside triphosphate binding | 17.89% (34/190) | 2.21 | 0.0 | 0.0 |
GO:0071704 | organic substance metabolic process | 27.89% (53/190) | 1.59 | 0.0 | 0.0 |
GO:0043226 | organelle | 11.05% (21/190) | 3.03 | 0.0 | 0.0 |
GO:0043229 | intracellular organelle | 11.05% (21/190) | 3.03 | 0.0 | 0.0 |
GO:0036094 | small molecule binding | 19.47% (37/190) | 2.04 | 0.0 | 0.0 |
GO:0008152 | metabolic process | 28.95% (55/190) | 1.54 | 0.0 | 0.0 |
GO:0009987 | cellular process | 28.42% (54/190) | 1.55 | 0.0 | 0.0 |
GO:0032555 | purine ribonucleotide binding | 17.89% (34/190) | 2.13 | 0.0 | 0.0 |
GO:0032553 | ribonucleotide binding | 17.89% (34/190) | 2.12 | 0.0 | 0.0 |
GO:0097367 | carbohydrate derivative binding | 17.89% (34/190) | 2.11 | 0.0 | 0.0 |
GO:0005488 | binding | 41.58% (79/190) | 1.12 | 0.0 | 0.0 |
GO:0043170 | macromolecule metabolic process | 23.16% (44/190) | 1.73 | 0.0 | 0.0 |
GO:0017076 | purine nucleotide binding | 17.89% (34/190) | 2.05 | 0.0 | 0.0 |
GO:0044238 | primary metabolic process | 26.32% (50/190) | 1.55 | 0.0 | 0.0 |
GO:1901265 | nucleoside phosphate binding | 17.89% (34/190) | 1.97 | 0.0 | 0.0 |
GO:0000166 | nucleotide binding | 17.89% (34/190) | 1.97 | 0.0 | 0.0 |
GO:1901564 | organonitrogen compound metabolic process | 19.47% (37/190) | 1.78 | 0.0 | 0.0 |
GO:0006139 | nucleobase-containing compound metabolic process | 11.05% (21/190) | 2.34 | 0.0 | 0.0 |
GO:0005524 | ATP binding | 13.68% (26/190) | 2.01 | 0.0 | 0.0 |
GO:0008150 | biological_process | 32.63% (62/190) | 1.08 | 0.0 | 0.0 |
GO:0006725 | cellular aromatic compound metabolic process | 11.05% (21/190) | 2.25 | 0.0 | 0.0 |
GO:0046483 | heterocycle metabolic process | 11.05% (21/190) | 2.25 | 0.0 | 0.0 |
GO:0043167 | ion binding | 22.11% (42/190) | 1.39 | 0.0 | 0.0 |
GO:1901360 | organic cyclic compound metabolic process | 11.05% (21/190) | 2.22 | 0.0 | 0.0 |
GO:0032559 | adenyl ribonucleotide binding | 13.68% (26/190) | 1.92 | 0.0 | 0.0 |
GO:0016070 | RNA metabolic process | 7.37% (14/190) | 2.88 | 0.0 | 0.0 |
GO:0006399 | tRNA metabolic process | 4.21% (8/190) | 4.16 | 0.0 | 0.0 |
GO:0030554 | adenyl nucleotide binding | 13.68% (26/190) | 1.82 | 0.0 | 0.0 |
GO:0006520 | amino acid metabolic process | 4.74% (9/190) | 3.76 | 0.0 | 0.0 |
GO:0044281 | small molecule metabolic process | 6.84% (13/190) | 2.9 | 0.0 | 0.0 |
GO:0090304 | nucleic acid metabolic process | 9.47% (18/190) | 2.3 | 0.0 | 0.0 |
GO:0043436 | oxoacid metabolic process | 5.26% (10/190) | 3.24 | 0.0 | 1e-06 |
GO:0019752 | carboxylic acid metabolic process | 5.26% (10/190) | 3.24 | 0.0 | 1e-06 |
GO:0006082 | organic acid metabolic process | 5.26% (10/190) | 3.23 | 0.0 | 1e-06 |
GO:0003676 | nucleic acid binding | 18.42% (35/190) | 1.39 | 0.0 | 1e-06 |
GO:0006418 | tRNA aminoacylation for protein translation | 3.16% (6/190) | 4.55 | 0.0 | 1e-06 |
GO:0034660 | ncRNA metabolic process | 4.21% (8/190) | 3.61 | 0.0 | 2e-06 |
GO:0004812 | aminoacyl-tRNA ligase activity | 3.16% (6/190) | 4.3 | 1e-06 | 3e-06 |
GO:0043038 | amino acid activation | 3.16% (6/190) | 4.3 | 1e-06 | 3e-06 |
GO:0043039 | tRNA aminoacylation | 3.16% (6/190) | 4.3 | 1e-06 | 3e-06 |
GO:0016875 | ligase activity, forming carbon-oxygen bonds | 3.16% (6/190) | 4.3 | 1e-06 | 3e-06 |
GO:0016874 | ligase activity | 3.68% (7/190) | 3.63 | 2e-06 | 9e-06 |
GO:0005525 | GTP binding | 4.21% (8/190) | 3.2 | 3e-06 | 1.4e-05 |
GO:0032561 | guanyl ribonucleotide binding | 4.21% (8/190) | 3.2 | 3e-06 | 1.4e-05 |
GO:0110165 | cellular anatomical entity | 13.16% (25/190) | 1.49 | 3e-06 | 1.6e-05 |
GO:0019001 | guanyl nucleotide binding | 4.21% (8/190) | 3.16 | 4e-06 | 1.7e-05 |
GO:0140101 | catalytic activity, acting on a tRNA | 3.16% (6/190) | 3.86 | 4e-06 | 1.8e-05 |
GO:0005575 | cellular_component | 13.68% (26/190) | 1.3 | 2e-05 | 9.2e-05 |
GO:0019538 | protein metabolic process | 12.63% (24/190) | 1.36 | 2.2e-05 | 0.0001 |
GO:0006457 | protein folding | 2.11% (4/190) | 4.57 | 2.4e-05 | 0.000107 |
GO:0090079 | translation regulator activity, nucleic acid binding | 2.11% (4/190) | 4.03 | 0.000107 | 0.000458 |
GO:0045182 | translation regulator activity | 2.11% (4/190) | 4.03 | 0.000107 | 0.000458 |
GO:0008135 | translation factor activity, RNA binding | 2.11% (4/190) | 4.03 | 0.000107 | 0.000458 |
GO:0006396 | RNA processing | 3.16% (6/190) | 2.97 | 0.000129 | 0.000545 |
GO:0008097 | 5S rRNA binding | 1.05% (2/190) | 6.52 | 0.000176 | 0.000735 |
GO:0140662 | ATP-dependent protein folding chaperone | 2.11% (4/190) | 3.77 | 0.000218 | 0.0009 |
GO:0019843 | rRNA binding | 1.58% (3/190) | 4.65 | 0.000227 | 0.000925 |
GO:0051082 | unfolded protein binding | 1.58% (3/190) | 4.58 | 0.00026 | 0.001047 |
GO:0044183 | protein folding chaperone | 2.11% (4/190) | 3.69 | 0.000269 | 0.00107 |
GO:0046040 | IMP metabolic process | 1.05% (2/190) | 6.2 | 0.000292 | 0.001134 |
GO:0006188 | IMP biosynthetic process | 1.05% (2/190) | 6.2 | 0.000292 | 0.001134 |
GO:0009127 | purine nucleoside monophosphate biosynthetic process | 1.05% (2/190) | 5.94 | 0.000437 | 0.001549 |
GO:0009124 | nucleoside monophosphate biosynthetic process | 1.05% (2/190) | 5.94 | 0.000437 | 0.001549 |
GO:0009123 | nucleoside monophosphate metabolic process | 1.05% (2/190) | 5.94 | 0.000437 | 0.001549 |
GO:0009126 | purine nucleoside monophosphate metabolic process | 1.05% (2/190) | 5.94 | 0.000437 | 0.001549 |
GO:0009156 | ribonucleoside monophosphate biosynthetic process | 1.05% (2/190) | 5.94 | 0.000437 | 0.001549 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 1.05% (2/190) | 5.94 | 0.000437 | 0.001549 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 1.05% (2/190) | 5.94 | 0.000437 | 0.001549 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 1.05% (2/190) | 5.94 | 0.000437 | 0.001549 |
GO:0016887 | ATP hydrolysis activity | 2.63% (5/190) | 2.92 | 0.000543 | 0.001906 |
GO:0016853 | isomerase activity | 2.63% (5/190) | 2.89 | 0.000607 | 0.002109 |
GO:0005694 | chromosome | 1.05% (2/190) | 5.35 | 0.001037 | 0.003526 |
GO:0006414 | translational elongation | 1.05% (2/190) | 5.35 | 0.001037 | 0.003526 |
GO:0006164 | purine nucleotide biosynthetic process | 1.58% (3/190) | 3.68 | 0.001673 | 0.005634 |
GO:0072522 | purine-containing compound biosynthetic process | 1.58% (3/190) | 3.65 | 0.001788 | 0.005962 |
GO:0017111 | ribonucleoside triphosphate phosphatase activity | 3.16% (6/190) | 2.23 | 0.001893 | 0.006186 |
GO:0003746 | translation elongation factor activity | 1.05% (2/190) | 4.94 | 0.00188 | 0.006204 |
GO:0140657 | ATP-dependent activity | 3.68% (7/190) | 2.0 | 0.002019 | 0.006533 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 7.89% (15/190) | 1.22 | 0.002122 | 0.006799 |
GO:0006265 | DNA topological change | 1.05% (2/190) | 4.82 | 0.002214 | 0.006958 |
GO:0003916 | DNA topoisomerase activity | 1.05% (2/190) | 4.82 | 0.002214 | 0.006958 |
GO:0016462 | pyrophosphatase activity | 3.16% (6/190) | 2.15 | 0.002527 | 0.007867 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 3.16% (6/190) | 2.11 | 0.002898 | 0.008937 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 3.16% (6/190) | 2.1 | 0.002954 | 0.009025 |
GO:0009165 | nucleotide biosynthetic process | 1.58% (3/190) | 3.38 | 0.003052 | 0.009156 |
GO:1901293 | nucleoside phosphate biosynthetic process | 1.58% (3/190) | 3.38 | 0.003052 | 0.009156 |
GO:0006163 | purine nucleotide metabolic process | 1.58% (3/190) | 3.27 | 0.003752 | 0.011155 |
GO:0072521 | purine-containing compound metabolic process | 1.58% (3/190) | 3.25 | 0.003941 | 0.011612 |
GO:0008837 | diaminopimelate epimerase activity | 0.53% (1/190) | 7.52 | 0.005448 | 0.015108 |
GO:0004018 | N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity | 0.53% (1/190) | 7.52 | 0.005448 | 0.015108 |
GO:0047661 | amino-acid racemase activity | 0.53% (1/190) | 7.52 | 0.005448 | 0.015108 |
GO:0003852 | 2-isopropylmalate synthase activity | 0.53% (1/190) | 7.52 | 0.005448 | 0.015108 |
GO:0006551 | leucine metabolic process | 0.53% (1/190) | 7.52 | 0.005448 | 0.015108 |
GO:0006189 | 'de novo' IMP biosynthetic process | 0.53% (1/190) | 7.52 | 0.005448 | 0.015108 |
GO:0009098 | leucine biosynthetic process | 0.53% (1/190) | 7.52 | 0.005448 | 0.015108 |
GO:0009117 | nucleotide metabolic process | 1.58% (3/190) | 3.02 | 0.006152 | 0.016917 |
GO:0003824 | catalytic activity | 22.63% (43/190) | 0.54 | 0.006309 | 0.017206 |
GO:0004252 | serine-type endopeptidase activity | 1.05% (2/190) | 3.94 | 0.007531 | 0.020206 |
GO:0006753 | nucleoside phosphate metabolic process | 1.58% (3/190) | 2.92 | 0.007485 | 0.020246 |
GO:0008173 | RNA methyltransferase activity | 1.05% (2/190) | 3.88 | 0.008157 | 0.021534 |
GO:0071103 | DNA conformation change | 1.05% (2/190) | 3.88 | 0.008157 | 0.021534 |
GO:0008033 | tRNA processing | 1.05% (2/190) | 3.82 | 0.008805 | 0.023061 |
GO:0003743 | translation initiation factor activity | 1.05% (2/190) | 3.77 | 0.009476 | 0.024622 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 1.58% (3/190) | 2.78 | 0.009618 | 0.024795 |
GO:0019136 | deoxynucleoside kinase activity | 0.53% (1/190) | 6.52 | 0.010866 | 0.025614 |
GO:0009082 | branched-chain amino acid biosynthetic process | 0.53% (1/190) | 6.52 | 0.010866 | 0.025614 |
GO:0004797 | thymidine kinase activity | 0.53% (1/190) | 6.52 | 0.010866 | 0.025614 |
GO:0004643 | phosphoribosylaminoimidazolecarboxamide formyltransferase activity | 0.53% (1/190) | 6.52 | 0.010866 | 0.025614 |
GO:0003937 | IMP cyclohydrolase activity | 0.53% (1/190) | 6.52 | 0.010866 | 0.025614 |
GO:0006432 | phenylalanyl-tRNA aminoacylation | 0.53% (1/190) | 6.52 | 0.010866 | 0.025614 |
GO:0004826 | phenylalanine-tRNA ligase activity | 0.53% (1/190) | 6.52 | 0.010866 | 0.025614 |
GO:0006353 | DNA-templated transcription termination | 0.53% (1/190) | 6.52 | 0.010866 | 0.025614 |
GO:0009081 | branched-chain amino acid metabolic process | 0.53% (1/190) | 6.52 | 0.010866 | 0.025614 |
GO:0019206 | nucleoside kinase activity | 0.53% (1/190) | 6.52 | 0.010866 | 0.025614 |
GO:0016597 | amino acid binding | 0.53% (1/190) | 6.52 | 0.010866 | 0.025614 |
GO:1901607 | alpha-amino acid biosynthetic process | 1.05% (2/190) | 3.71 | 0.010169 | 0.026012 |
GO:0090407 | organophosphate biosynthetic process | 1.58% (3/190) | 2.66 | 0.01207 | 0.028248 |
GO:0004175 | endopeptidase activity | 1.58% (3/190) | 2.65 | 0.012446 | 0.028924 |
GO:0046390 | ribose phosphate biosynthetic process | 1.05% (2/190) | 3.48 | 0.013953 | 0.031538 |
GO:0009152 | purine ribonucleotide biosynthetic process | 1.05% (2/190) | 3.48 | 0.013953 | 0.031538 |
GO:0009260 | ribonucleotide biosynthetic process | 1.05% (2/190) | 3.48 | 0.013953 | 0.031538 |
GO:0016741 | transferase activity, transferring one-carbon groups | 2.11% (4/190) | 2.13 | 0.013683 | 0.031575 |
GO:0031406 | carboxylic acid binding | 0.53% (1/190) | 5.94 | 0.016256 | 0.03291 |
GO:0019238 | cyclohydrolase activity | 0.53% (1/190) | 5.94 | 0.016256 | 0.03291 |
GO:0016842 | amidine-lyase activity | 0.53% (1/190) | 5.94 | 0.016256 | 0.03291 |
GO:0019205 | nucleobase-containing compound kinase activity | 0.53% (1/190) | 5.94 | 0.016256 | 0.03291 |
GO:0043177 | organic acid binding | 0.53% (1/190) | 5.94 | 0.016256 | 0.03291 |
GO:0046451 | diaminopimelate metabolic process | 0.53% (1/190) | 5.94 | 0.016256 | 0.03291 |
GO:0046938 | phytochelatin biosynthetic process | 0.53% (1/190) | 5.94 | 0.016256 | 0.03291 |
GO:0009085 | lysine biosynthetic process | 0.53% (1/190) | 5.94 | 0.016256 | 0.03291 |
GO:0009089 | lysine biosynthetic process via diaminopimelate | 0.53% (1/190) | 5.94 | 0.016256 | 0.03291 |
GO:0016855 | racemase and epimerase activity, acting on amino acids and derivatives | 0.53% (1/190) | 5.94 | 0.016256 | 0.03291 |
GO:0036361 | racemase activity, acting on amino acids and derivatives | 0.53% (1/190) | 5.94 | 0.016256 | 0.03291 |
GO:0016756 | glutathione gamma-glutamylcysteinyltransferase activity | 0.53% (1/190) | 5.94 | 0.016256 | 0.03291 |
GO:0019748 | secondary metabolic process | 0.53% (1/190) | 5.94 | 0.016256 | 0.03291 |
GO:0006553 | lysine metabolic process | 0.53% (1/190) | 5.94 | 0.016256 | 0.03291 |
GO:0044550 | secondary metabolite biosynthetic process | 0.53% (1/190) | 5.94 | 0.016256 | 0.03291 |
GO:0046937 | phytochelatin metabolic process | 0.53% (1/190) | 5.94 | 0.016256 | 0.03291 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 2.11% (4/190) | 2.04 | 0.016884 | 0.033973 |
GO:0003690 | double-stranded DNA binding | 1.05% (2/190) | 3.39 | 0.015612 | 0.035049 |
GO:0008652 | amino acid biosynthetic process | 1.05% (2/190) | 3.27 | 0.018251 | 0.036502 |
GO:1901605 | alpha-amino acid metabolic process | 1.05% (2/190) | 3.2 | 0.020107 | 0.039972 |
GO:0050997 | quaternary ammonium group binding | 0.53% (1/190) | 5.52 | 0.021616 | 0.041232 |
GO:0033588 | elongator holoenzyme complex | 0.53% (1/190) | 5.52 | 0.021616 | 0.041232 |
GO:0030976 | thiamine pyrophosphate binding | 0.53% (1/190) | 5.52 | 0.021616 | 0.041232 |
GO:0016743 | carboxyl- or carbamoyltransferase activity | 0.53% (1/190) | 5.52 | 0.021616 | 0.041232 |
GO:0010038 | response to metal ion | 0.53% (1/190) | 5.52 | 0.021616 | 0.041232 |
GO:0016742 | hydroxymethyl-, formyl- and related transferase activity | 0.53% (1/190) | 5.52 | 0.021616 | 0.041232 |
GO:0140097 | catalytic activity, acting on DNA | 1.58% (3/190) | 2.36 | 0.020892 | 0.041283 |
GO:0000287 | magnesium ion binding | 1.05% (2/190) | 3.06 | 0.024044 | 0.0456 |
GO:0009150 | purine ribonucleotide metabolic process | 1.05% (2/190) | 3.0 | 0.026121 | 0.048699 |
GO:0009259 | ribonucleotide metabolic process | 1.05% (2/190) | 3.0 | 0.026121 | 0.048699 |
GO:0019693 | ribose phosphate metabolic process | 1.05% (2/190) | 3.0 | 0.026121 | 0.048699 |
GO:0019438 | aromatic compound biosynthetic process | 2.11% (4/190) | 1.83 | 0.027016 | 0.049256 |
GO:0002098 | tRNA wobble uridine modification | 0.53% (1/190) | 5.2 | 0.026947 | 0.049402 |
GO:0005759 | mitochondrial matrix | 0.53% (1/190) | 5.2 | 0.026947 | 0.049402 |
GO:0016854 | racemase and epimerase activity | 0.53% (1/190) | 5.2 | 0.026947 | 0.049402 |